OpenAI Explores Medical ChatGPT, MIT Develops AI for 3D Genomic Calculation & much more

Hi there, In this edition of Life AI Weekly, we're diving into the latest advancements in AI technology within the healthcare sector. Oregon is making headlines with a new bill that aims to restrict the use of the title 'nurse' to human professionals only, amidst the rise of AI health assistants. Meanwhile, Medsender has successfully secured $5 million in Series A funding, which will be used to enhance their AI-driven healthcare communication platform. Additionally, Datar Cancer Genetics has launched Exacta AI, a new tool designed to improve cancer treatment outcomes. On the innovation front, Drive Health has introduced Nurse Avery, an AI health assistant, to support healthcare providers. These developments highlight the growing integration of AI in healthcare, promising to reshape patient care and medical practices.

Waterlily, a San Francisco-based fintech company, has secured $7 million in seed funding led by Brewer Lane Ventures to enhance its AI-driven long-term care planning services. The National Reconstruction Fund Corporation of Australia has allocated $32 million to Harrison.ai, a Sydney-based startup specializing in AI for medical diagnostics. Suki has received investment from Zoom Ventures to enhance AI integration in healthcare, focusing on AI-driven clinical notes for Zoom's Workplace for Clinicians.

OSE Immunotherapeutics and Scienta Lab have partnered to use AI for modeling inflammatory diseases and identifying biomarkers for immunotherapies. Researchers from the Ragon Institute and MIT have developed MUNIS, an AI tool for predicting CD8+ T cell epitopes to accelerate vaccine development. Ryght AI and Cancer Research South Australia (CRSA) are collaborating to enhance cancer clinical trials with AI technology. Lantern Pharma has advanced its AI platform, RADR, to identify targets for antibody-drug conjugates in cancer treatment. Chugai Pharmaceutical, SoftBank Corp., and SB Intuitions Corp. are collaborating on using generative AI in drug development to improve clinical processes and reduce costs.

Cognizant has announced an expanded agreement with Medidata to enhance support for life sciences clients by leveraging AI-powered technologies to improve clinical trial development. A study reveals that a multimodal machine learning model using coronary computed tomography angiography and cardiac MRI data predicts major adverse cardiovascular events with 86% accuracy in patients with obstructive coronary artery disease. Researchers at the Massachusetts Institute of Technology have created a generative AI model that predicts 3D DNA structures in minutes, enhancing the analysis of chromatin and gene expression.

Cleveland Clinic Genome Center researchers have utilized AI to identify genetic factors in Parkinson’s disease and explore drug repurposing opportunities. Google's X has launched Heritable Agriculture, a startup using AI to enhance crop yields through plant genome analysis. MYndspan and BIOS Health are collaborating to improve access to precision neuroscience by combining MEG brain scans with AI-driven neural data analysis.

Medsender raised $5 million in Series A funding to enhance its AI-powered workflow platform. Datar Cancer Genetics launched Exacta AI for personalized cancer treatment. Drive Health introduced Nurse Avery, an AI health assistant, in collaboration with Google Public Sector.